Capital Advisors Ltd’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
11
﹤0.01% 1541
2026
Q1
$0 Hold
11
﹤0.01% 1552
2025
Q4
$0 Buy
11
+5
+83% +$30 ﹤0.01% 1526
2025
Q3
$0 Sell
6
-37
-86% -$213 ﹤0.01% 1516
2025
Q2
$0 Sell
43
-1,778
-98% -$10.7K ﹤0.01% 1576
2025
Q1
$15K Sell
1,821
-78
-4% -$654 ﹤0.01% 675
2024
Q4
$16K Buy
1,899
+101
+6% +$810 ﹤0.01% 667
2024
Q3
$14K Sell
1,798
-11
-0.6% -$101 ﹤0.01% 708
2024
Q2
$19K Hold
1,809
﹤0.01% 603
2024
Q1
$22K Hold
1,809
﹤0.01% 570
2023
Q4
$20K Hold
1,809
﹤0.01% 569
2023
Q3
$25K Buy
+1,809
New +$26.5K ﹤0.01% 517
2023
Q1
Sell
-22
Closed 1479
2022
Q4
$0 Hold
22
﹤0.01% 1551
2022
Q3
$0 Buy
+22
New +$314 ﹤0.01% 1458

Other funds holding PTEN

Capital Advisors Ltd's PTEN Position: Q2 2026 in Review

Capital Advisors Ltd held its Patterson-UTI (PTEN) position steady in Q2 2026 at 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Capital Advisors Ltd first reported a position in PTEN in Q3 2022 and has held it in 14 quarters since. The position peaked at $25K in Q3 2023. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Capital Advisors Ltd held 11 shares of Patterson-UTI worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1541 holding.
  • Capital Advisors Ltd first reported a position in Patterson-UTI in Q3 2022 and has held it in 14 quarters since.
  • Capital Advisors Ltd's Patterson-UTI position peaked at $25K in Q3 2023.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.